Salud
Consulting firm McKinsey to pay $650 million to settle opioid charges in US
McKinsey & Co has agreed to pay $650 million to settle allegations that it provided advice to Purdue Pharma on how to ‘turbo-accelerate’ sales of
The companies say the regulatory conditions of Novo Holdings’ $16.5bn deal with Catalent have been met
All regulatory closing conditions related to Novo Holdings’ $16.5bn acquisition of US drugmaker Catalent the companies said on Saturday that the deal has been completed,
Novo Nordisk to invest $1.2bn in new rare disease drug plant in Denmark
Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new plant in Odense, Denmark, to produce drugs for rare diseases, it
FDA approves Checkpoint’s skin cancer drug
The US Food and Drug Administration said it approved Checkpoint Therapeutics’ drug for the treatment of a type of cancer in the outer layer of
FDA approves Neurocrine Biosciences’ genetic disorder drug
The US Food and Drug Administration has approved Neurocrine Biosciences’ drug to treat a type of genetic disorder, the health regulator’s website showed. The drug
Consulting firm McKinsey to pay $650 million to settle US opioid charges
The US Food and Drug Administration has approved Neurocrine Biosciences’ drug to treat a type of genetic disorder, the health regulator’s website showed. The drug
Lilly to offer single-use vials of weight loss drug on Ro’s telemedicine platform
Telemedicine company Ro said Wednesday it will offer single-use vials of Eli Lilly’s weight-loss drug Zepbound for obese patients has become the first alternative platform
Healthcare leaders consider patient outrage after UnitedHealthcare killing
Healthcare companies are taking a step back to better understand the patient experience after a powerful U.S. health insurer executive was killed last week, executives
Healthcare stocks fall as lawmakers push bill to crack down on drug middlemen
Shares of companies that own pharmacy benefit managers fell Wednesday after the introduction of a bipartisan bill that would require health insurers or pharmaceutical intermediaries
WHO reports that malaria cases increased again in 2023, with African children hardest hit
According to a new report from the World Health Organisation, there were about 11 million more malaria cases in 2023 than in 2022, reaching an